Dr. Fainareti Zervou, MD

Dr. Zervou practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Zervou's NPI, 1427436005, was assigned on May 14, 2015. Dr. Zervou holds New York license 298733.

Dr. Zervou's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Zervou's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Zervou is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Zervou to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zervou practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Zervou's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Zervou's licenses on file in 2 states: New York and Rhode Island.

CMS data shows 443 Medicare services from Dr. Zervou across 4 procedure codes in 2024, for 138 Medicare patients. Medicare paid $47,666 for them.

CMS counts 138 Medicare patients who saw Dr. Zervou in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 44% are also on Medicaid. Their average risk score is 5.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zervou's median patient age at 59, with 39% women.

In 2024, Dr. Zervou wrote 144 Medicare Part D claims for 37 patients. 77% of them were for generic drugs. CMS names the drug for 66 of them, across 5 drugs with 11 or more claims each, at $213,153 in total drug cost. In 2023, CMS named 58 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Zervou for performance year 2024, reported as part of a group. Dr. Zervou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zervou as offering telehealth.

Dmand AI links 48 papers to Dr. Zervou, published from 2014 to 2023. 2014 was the busiest year, with 8. The most frequent topics are Clostridioides difficile, Anti-Bacterial Agents and Staphylococcal Infections. Dr. Zervou has published most often in PLoS One. Dr. Zervou's most frequent co-authors are Maria E. Aguero-Rosenfeld, MD, Suresh Paudel, MD and Prithiv Joel Prasad, MBBS.